Clinical Trial Update: Impact of Atorvastatin on Prostate Cancer Progression During ADT [Phase 3]

View source ↗

Summary

Phase 3 trial investigating the impact of atorvastatin on progression of metastatic or recurrent prostate cancer during androgen deprivation therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Tampere University Hospital | Conditions: Metastatic Prostate Cancer, Recurrent Prostate Cancer | Phase 3 | Status: UNKNOWN